Effective Immunomodulatory Treatment of Escherichia coli Experimental Sepsis with Thalidomide

Thalidomide, an agent which inhibits biosynthesis of tumor necrosis factor alpha (TNF-α) and which is used to treat a variety of chronic inflammatory conditions, was investigated as therapy for experimental sepsis. Sepsis was induced by intraperitoneal injection of 10(7) CFU of Escherichia coli per...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Giamarellos-Bourboulis, Evangelos J., Poulaki, Helen, Kostomitsopoulos, Nikolaos, Dontas, Ismene, Perrea, Despina, Karayannacos, Panayotis E., Giamarellou, Helen
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2003
主題:	Experimental Therapeutics
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC166096/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12878503/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.8.2445-2449.2003
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!